P3.01-32 an Open-Label, Non-Randomized, Biomarker Study of Concordance in Non-Invasive and Tissue Tests for T790M Detection in NSCLC

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1592
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P2.01-32 Economic Evaluation of Diagnostic Platforms for T790M Detection in Post EGFR-TKI NSCLC in Brazil

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.01-086 Biomarker Testing Trends and Treatment Patterns in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients in the United States

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Gemcitabine and Docetaxel Combination Chemotherapy for Advanced Bone and Soft Tissue Sarcomas: Protocol for an Open-Label, Non-Randomised, Phase 2 Study

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

P3.01-13 Prognosis of Non-Driver, Never Smoker Metastatic Non-Small Lung Cancer (NSCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Non-Invasive Tests and Markers for Liver Fibrosis

Sohag Medical Journal
2017English

Non-Invasive Vascular Function Tests:

Circulation Journal
MedicineCardiovascular MedicineCardiology
2010English

Efficacy of Bimin Decoction for Patients With Perennial Allergic Rhinitis: An Open-Label Non-Inferiority Randomized Controlled Trial

Trials
MedicinePharmacology
2019English

Non-Invasive Tissue Oximetry

English

Comparison of Non-Invasive Tests With Invasive Tests in the Diagnosis of Celiac Disease

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy